Alnylam raises revenue outlook as heart drug sees quick uptake Earnings report had been highly anticipated as a sign of therapy’s competitiveness vs. BridgeBio medication

https://www.statnews.com/2025/07/31/alnylam-amvuttra-attr-cm-earnings/